Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS ▴
IOVA	Iovance Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$263.50M	-$390.98M	-148.4%	-56.0%	60.6%	-$1.09
AUTL	Autolus Therapeutics plc Manufacturing · Year ended 2025-12-31 · USD	$75.39M	-$287.53M	-381.4%	-161.4%	644.9%	-$1.08
ZURA	Zura Bio Ltd Manufacturing · Year ended 2025-12-31 · USD	n/a	-$68.65M	n/a	-67.6%	n/a	-$1.06
DBVT	DBV Technologies S.A. Manufacturing · Year ended 2025-12-31 · USD	$5.64M	-$146.95M	n/m	-87.1%	35.8%	-$1.05
BCAB	BioAtla, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.61M	n/a	-164.7%	n/a	-$1.01
TCRX	TScan Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.32M	-$129.77M	n/m	-105.4%	266.7%	-$1.00
SANA	Sana Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$244.17M	n/a	-151.8%	n/a	-$0.96
ALLO	Allogene Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$190.89M	n/a	-65.3%	-100.0%	-$0.87
ZEOX	Zeo ScientifiX, Inc. Manufacturing · Year ended 2025-10-31 · USD	$5.20M	-$5.52M	-106.2%	n/a	12.5%	-$0.86
BEAM	Beam Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$139.74M	-$79.99M	-57.2%	-6.5%	120.0%	-$0.81
ATYR	aTYR PHARMA INC Manufacturing · Year ended 2025-12-31 · USD	$190.0K	-$74.12M	n/m	-109.8%	-19.1%	-$0.80
SABS	SAB Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$13.27M	n/a	8.8%	n/a	-$0.79
CADL	Candel Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$38.18M	n/a	-73.5%	n/a	-$0.72
IMCR	Immunocore Holdings plc Manufacturing · Year ended 2025-12-31 · USD	$400.02M	-$35.51M	-8.9%	-9.3%	29.0%	-$0.71
CRDF	Cardiff Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$593.0K	-$45.85M	n/m	-101.0%	-13.2%	-$0.69
APTN	Adaptin Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$5.17M	n/a	n/a	n/a	-$0.66
TNYA	Tenaya Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$90.60M	n/a	-73.5%	n/a	-$0.59
CRIS	Curis Inc Manufacturing · Year ended 2025-12-31 · USD	$9.44M	-$7.58M	-80.3%	-138.8%	-13.4%	-$0.58
AVXL	Anavex Life Sciences Corp. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$46.38M	n/a	-48.9%	n/a	-$0.54
ELOX	Eloxx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$6.00M	n/a	n/a	-100.0%	-$0.49
IKT	Inhibikase Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$48.26M	n/a	-27.9%	n/a	-$0.49
SGMOQ	Sangamo Therapeutics, Inc Manufacturing · Year ended 2025-12-31 · USD	$39.55M	-$122.93M	-310.8%	n/a	-31.6%	-$0.44
LIMN	Liminatus Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.21M	n/a	n/a	n/a	-$0.43
ADPT	Adaptive Biotechnologies Corp Manufacturing · Year ended 2025-12-31 · USD	$276.98M	-$59.50M	-21.5%	-27.2%	54.8%	-$0.39
IBRX	ImmunityBio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$113.29M	-$351.40M	-310.2%	n/a	668.3%	-$0.38

Rows per page: 2550 100